MIXTARD 30 PENFILL

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
06-06-2021
Valmisteyhteenveto Valmisteyhteenveto (SPC)
18-01-2021

Aktiivinen ainesosa:

INSULIN (HUMAN)

Saatavilla:

NOVO NORDISK LTD., ISRAEL

ATC-koodi:

A10AD01

Lääkemuoto:

SUSPENSION FOR INJECTION

Koostumus:

INSULIN (HUMAN) 100 IU/ML

Antoreitti:

S.C

Prescription tyyppi:

Required

Valmistaja:

NOVO NORDISK A/S, DENMARK

Terapeuttinen ryhmä:

INSULIN (HUMAN)

Terapeuttinen alue:

INSULIN (HUMAN)

Käyttöaiheet:

Therapeutic indications Mixtard is indicated for treatment of diabetes mellitus.

Valtuutus päivämäärä:

2020-07-31

Pakkausseloste

                                1
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
THIS MEDICINE IS DISPENSED WITH A DOCTOR’S PRESCRIPTION ONLY
MIXTARD 30 PENFILL
100 IU/ML
SUSPENSION FOR INJECTION IN CARTRIDGE
ACTIVE INGREDIENT: human insulin, 100 international units/ml
INACTIVE INGREDIENTS AND ALLERGENS IN THIS MEDICINE: See section 6
Additional
information.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet
contains concise information about this medicine. If you have any
further questions,
consult your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may harm
them, even if it seems to you that their medical condition is similar
to yours.
1. WHAT IS THIS MEDICINE INTENDED FOR?
Mixtard30 Penfill is used to treat diabetes.
THERAPEUTIC GROUP: diabetes medicines, medium- or long-acting insulins
and analogs for injection
with fast-acting insulins. Human insulin.
Mixtard 30 Penfill is human insulin composed of a mix of both a
fast-acting and a long-acting
insulin. It is used to reduce the high blood sugar level in patients
with diabetes.
Diabetes is a disease where your body does not produce enough insulin
to control the level of your
blood sugar. Treatment with Mixtard 30 Penfill helps to prevent
complications from your diabetes.
Mixtard 30 Penfill will start to lower your blood sugar about 30
minutes after you inject it, and the
effect will last for approximately 24 hours.
2. BEFORE USING THIS MEDICINE
DO NOT USE THIS MEDICINE:

if you are sensitive (allergic) to human insulin or any of the other
ingredients in this medicine
(see section 6, ‘Additional information’)

if you suspect hypoglycemia (low blood sugar) is starting, see section
4 under ‘Summary of
serious and very common side effects’

in insulin infusion pumps

if the cartridge or the device containing the cartridge is dropped,
damaged or crushed

if the cartridge has not been stored correctly or if it has frozen -
see section 5

if the resu
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste arabia 06-06-2021
Pakkausseloste Pakkausseloste heprea 06-06-2021

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia